Blood Res.  2013 Jun;48(2):154-156. 10.5045/br.2013.48.2.154.

Fungemia due to Trichosporon dermatis in a patient with refractory Burkitt's leukemia

• Hashino S
• Takahashi
• Morita R
• Kanamori H
• Onozawa M
• Kawamura T
• Kahata K
• Kondo T
• Tokimatsu
• Sugita T
• Akizawa K
• Asaka M

• KMID: 2172918
• DOI: http://doi.org/10.5045/br.2013.48.2.154

Abstract

No abstract available.

MeSH Terms

Burkitt Lymphoma
Fungemia
Humans
Trichosporon

Figure

• 

  Fig. 1 Time course for a patient with refractory Burkitt's leukemia who suffered from fungemia due to Trichosporon dermatis after chemotherapy. Abbreviations: R-hyper CVAD, rituximab+cyclophosphamide hydrate+vincristine sulfate+doxorubicin hydrochloride+dexamethasone; MTX, methotrexate; R-IVAC, rituximab+ifosfamide+etoposide+cytarabine; R-CODOX-M, rituximab+cyclophosphamide hydrate+vincristine sulfate+doxorubicin hydrochloride+methotrexate; PBSCC, peripheral blood stem cell collection; R-ASHAP, rituximab+doxorubicin hydrochloride+methylprednisolone+cytarabine+cisplatin; MEAM, ranimustine+etoposide+cytarabine+melphalan; FLCZ, fluconazole; VRCZ, voriconazole; ITCZ, itraconazole; L-AMB, liposomal amphotericin B; CVC, central venous catheter.

Reference

1. Ruan SY, Chien JY, Hsueh PR. Invasive trichosporonosis caused by Trichosporon asahii and other unusual Trichosporon species at a medical center in Taiwan. Clin Infect Dis. 2009; 49:e11–e17. PMID: 19489711.

2. Girmenia C, Pagano L, Martino B, et al. Invasive infections caused by Trichosporon species and Geotrichum capitatum in patients with hematological malignancies: a retrospective multicenter study from Italy and review of the literature. J Clin Microbiol. 2005; 43:1818–1828. PMID: 15815003.

3. Sugita T, Takashima M, Nakase T, Ichikawa T, Ikeda R, Shinoda T. Two new yeasts, Trichosporon debeurmannianum sp. nov. and Trichosporon dermatis sp. nov., transferred from the Cryptococcus humicola complex. Int J Syst Evol Microbiol. 2001; 51:1221–1228. PMID: 11411691.

4. Sugita T, Nakajima M, Ikeda R, Matsushima T, Shinoda T. Sequence analysis of the ribosomal DNA intergenic spacer 1 regions of Trichosporon species. J Clin Microbiol. 2002; 40:1826–1830. PMID: 11980969.

5. Ahmad S, Al-Mahmeed M, Khan ZU. Characterization of Trichosporon species isolated from clinical specimens in Kuwait. J Med Microbiol. 2005; 54:639–646. PMID: 15947428.

6. Sugita T, Ikeda R, Nishikawa A. Analysis of Trichosporon isolates obtained from the houses of patients with summer-type hypersensitivity pneumonitis. J Clin Microbiol. 2004; 42:5467–5471. PMID: 15583267.

7. Gunn SR, Reveles XT, Hamlington JD, Sadkowski LC, Johnson-Pais TL, Jorgensen JH. Use of DNA sequencing analysis to confirm fungemia due to Trichosporon dermatis in a pediatric patient. J Clin Microbiol. 2006; 44:1175–1177. PMID: 16517924.

8. Fekkar A, Brun S, D'Ussel M, et al. Serum cross-reactivity with Aspergillus galactomannan and cryptococcal antigen during fatal disseminated Trichosporon dermatis infection. Clin Infect Dis. 2009; 49:1457–1458. PMID: 19824853.

9. Chagas-Neto TC, Chaves GM, Melo AS, Colombo AL. Bloodstream infections due to Trichosporon spp.: species distribution, Trichosporon asahii genotypes determined on the basis of ribosomal DNA intergenic spacer 1 sequencing, and antifungal susceptibility testing. J Clin Microbiol. 2009; 47:1074–1081. PMID: 19225102.

10. Rodriguez-Tudela JL, Diaz-Guerra TM, Mellado E, et al. Susceptibility patterns and molecular identification of Trichosporon species. Antimicrob Agents Chemother. 2005; 49:4026–4034. PMID: 16189076.

11. Trifilio S, Pennick G, Pi J, et al. Monitoring plasma voriconazole levels may be necessary to avoid subtherapeutic levels in hematopoietic stem cell transplant recipients. Cancer. 2007; 109:1532–1535. PMID: 17351937.

12. Vazquez JA. Trichosporon infection. Curr Fungal Infect Rep. 2010; 4:52–58.